GEN Exclusives

More »

GEN News Highlights

More »
Jan 22, 2013

BAC Joins Life Technologies' Family of Companies

  • Life Technologies acquired Netherlands-based BAC, which is involved in the discovery, development, and manufacture of protein purification products. The acquisition expands Life’s capabilities and product offerings in the growing market of biopharmaceutical research and manufacturing, according to a Life Technologies official.

    “Our acquisition of BAC BV positions Life Technologies as a leading provider of end-to-end solutions that are widely utilized in the bioprocess workflow,” explained Tony Hunt, head of bioproduction at Life Tech. “Combining BAC’s current portfolio and pipeline with our pre-existing portfolio expands Life’s product offering and enables us to compete more fully across the protein purification market.”

    Life Technologies’ Gibco® brand is targeted at the cell culture media market, and the company more recently integrated its Poros® brand of chromatography resins for purification of therapeutic products into the bioproduction portfolio. Hunt noted that the acquisition expands Life’s existing portfolio by adding BAC’s affinity ligands to the Poros resins. Life also offers the Applied Biosystems® SEQ molecular kits for contaminant and impurity testing of biotherapeutic products, added Hunt.

    It’s been estimated that downstream processing and purification activities are responsible for up to 60% of the entire production cost.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Children and Antipsychotic Drugs

Do you think children and adolescents with behavioral problems are overmedicated?